New Business Model Equals Increasing Revenues for ScripsAmerica Analyst Report
NEW YORK, May 29, 2014 /PRNewswire/ -- ScripsAmerica, Inc. (OTCQB: SCRC) offers fulfillment of prescription and over the counter drug orders. To fulfill purchase orders from customers, the company processes orders to the end user's desired specifications. The company's capabilities range from unit of use packaging for in-patient nursing homes and hospitals to bulk packaging for government and international organizations.
Last year the company restructured its business model, due to a distribution arrangement that was causing a drop in revenue. In the company's Q1 2014 ended March 31st revenue doubled.
The company is marketing its own new product, a pain reliever and fever reducer pill that dissolves quickly and comes in in fruit flavors, aimed at the children's OTC market.
A full report on SCRC that includes recent events, financial position, review of current business model, risk factors, analyst summary, and recommendation can be viewed by using the following link:
Copy and paste to browser may be required.
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is written and authored by Mark Bonacci, Analyst. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
A full disclaimer can be found by viewing the full analyst report.
SOURCE Small Cap Specialists, LLC